NorthWest Biotherapeutics Inc (NWBO)

[H2R]

A BO would make sense

NWBO is a micro company in the world of BP. To bring DCVax to the fore, NWBO will not only need to move it past the FDA hurdles, but compete with major established companies and interests at large. (Those interests in some shape or form are what I believe contribute to the trolling of NWBO.)

And it's not just pharma. For instance, oncologists (in the US at least) tend to benefit from prescribing chemo:

Among cancer doctors, it is called the chemotherapy concession. At a time when overall spending on prescription drugs is soaring, cancer specialists are pocketing hundreds of millions of dollars each year by selling drugs to patients -- a practice that almost no other doctors follow.

The cancer specialists can make huge sums -- often the majority of their practice revenue -- from the difference between what they pay for the drugs and what they charge insurers and government programs. But some private health insurers are now studying ways to reduce these profits, and the issue is getting close attention in Congress.

https://www.nytimes.com/2003/01/26/us/drug-sales-bring-huge-profits-and-scrutiny-to-cancer-doctors.html
and
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565179/

In 2015, Forbes published an article about the cancer revenue per year: at the time, it was around $100B.
https://www.forbes.com/sites/matthewherper/2015/05/05/cancer-drug-sales-approach-100-billion-and-could-increase-50-by-2018/#1fb1fdee2dc6

Then you have to negotiate with insurances and their tiers, payers, etc.

And of course, the Europeans, the Japanese, the Chinese equivalent of the FDA and the rest.

For the sake of patients, I really would prefer a major player to buy NWBO out to get DCVax out sooner in this market landscape. It may not be maximizing NWBO shareholders profit, but it would be good for us Longs and definitely for patients.

Best of Luck to Patients, NWBO, and Longs!